Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessCase report

Extrapulmonary small cell sarcinoma: involvement of the brain without evidence of extracranial malignancy by serial PET/CT scans

Christopher N Hueser1 email, Nghi C Nguyen2 email, Medhat Osman2 email, Necat Havlioglu3 email and Anjali J Patel4 email

Department of Internal Medicine, Division of Hematology and Oncology, St. Louis University Hospital, St. Louis, MO 63110, USA

Department of Nuclear Medicine, St. Louis University Hospital, St. Louis, MO 63110, USA

Department of Pathology, St. Louis University Hospital, St. Louis, MO 63110, USA

Department of Anesthesia and Critical Care, St. Louis University Hospital, St. Louis, MO 63110, USA

author email corresponding author email

World Journal of Surgical Oncology 2008, 6:102doi:10.1186/1477-7819-6-102

Published: 25 September 2008

Abstract

Background

Extrapulmonary small cell carcinoma (EPSCC) involving the brain is a rare manifestation of an uncommon tumor type.

Case presentation

We report a 59 year-old Caucasian female diagnosed with an EPSCC involving the left parietal lobe without detectable extracranial primary tumor followed by serial positron emission tomography/computed tomography (PET/CT) imaging. Histopathological examination at both initial presentation and recurrence revealed small cell carcinoma. Serial PET/CT scans of the entire body failed to reveal any extracranial [18F]2-fluoro-2-deoxy-D-glucose (FDG) avid lesions at either diagnosis or follow-up.

Conclusion

Chemotherapy may show a transient response in the treatment of EPSCC. Further studies are needed to help identify optimal treatment strategies. Combination PET/CT technology may be a useful tool to monitor EPSCC and assess for an occult primary malignancy.


© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.